🧠 Methylene Blue Smear Campaign Is in Full Swing –

What's The Truth?

Follow: Twitter | Instagram | Telegram | Gab | Facebook
Truth Lives Here: Rumble | Rokfin | Odysee | Brighteon | Bitchute | YouTube
Websites: MaryamHenein.com | HoneyColony.com

Let’s talk methylene blue. I want to put it on record that, once again, HoneyColony was one of the first to offer a liposomal, pharmaceutical-grade product. Like two years ago!

I personally tried it in 2017 -- pre-p$andemic and, due to its benefits, I knew it was going to make a splash. I was right.

But recently, respected health professionals began a smear campaign that smells like a panic attack. At the same time, others, such as Alex Jones and Roseanne Barr, have jumped on the blue bandwagon.

First Off: What Is Methylene Blue?

It is a synthetic dye synthesized in 1876 and first used to treat malaria. Crosses the blood-brain barrier. Boosts mitochondrial function. Protects neurons. Cheap. Doesn’t need a prescription.

And that’s precisely why they’re coming for it.

The headlines go something like this:

“Methylene blue is toxic because it’s synthetic and derived from petroleum!”

Cue the fear porn. Except—here’s the deal: if we’re throwing out MB for being “from petroleum,” then we’d also have to toss out most of the entire pharmaceutical industry and a considerable number of supplements and lab-tested compounds.

Read more here about how MB is made.

Methylene blue has been safely used for over 100 years, both intravenously and orally. I've taken it intravenously against parasites, as an energy boost, and for mitochondrial function.

So why the sudden slander?

Because it’s effective, but not profitable, it's like the Smurf campaign against colloidal silver all over again!

If you'd like to try a small 0.5-ounce bottle. Get 18% OFF coupon code -- beeblue

Unpacking the Methylene Blue Backlash

​Articles that label methylene blue (MB) as a "lethal neurotoxin" use misdirected and alarmist claims. All supplements should be used with caution and tailored to the individual’s specific objectives. While MB has mild, reversible MAOI properties at high doses, it is not chemically identical to dangerous psychiatric drugs like Thorazine or traditional irreversible MAOIs.

At low doses, MB has a well-established safety profile, with FDA-approved uses for conditions such as methemoglobinemia and off-label applications in neuroprotection and mitochondrial support. The author equates activation or cognitive enhancement with toxicity, disregarding peer-reviewed research showing MB's neuroprotective and cognitive benefits when used responsibly.

Key issues with the article include:

• False equivalency: Structural similarity ≠ functional toxicity.

• Dose confusion: High-dose risks ≠ low-dose therapeutic benefits.

• Philosophical bias: The Author’s anti-psychiatry stance distorts objective analysis.

• Overlooked context: MB is WHO-listed and used globally with positive outcomes.

• Fear-based framing: Targets health freedom communities without citing concrete data on adverse events.

If you'd like to try a small 0.5-ounce bottle. Get 18% OFF coupon code -- beeblue